IL224288A
(en )
2015-02-26
Derivatives of substituted pyrazolamide, pharmaceutical compositions comprising the same and uses thereof
MY181898A
(en )
2021-01-12
Heterocyclic compounds and uses thereof
AU333421S
(en )
2010-10-28
Showerhead
NZ603151A
(en )
2013-10-25
N3-substituted-n1-sulfonyl-5-fluoropyrimidinone derivatives
WO2012030993A3
(en )
2012-06-21
Skin compositions and methods of use thereof
PH12012502016A1
(en )
2013-01-21
Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
PL2768937T3
(en )
2016-07-29
Formulations, their use as or for the manufacture of dishwashing agents and their manufacture
CL2013000016A1
(en )
2013-04-19
Compounds derived from imidazopyridine; preparation procedure; Pharmaceutical composition and its use in the treatment of cancer.
IL232515A0
(en )
2014-06-30
Nadph oxidase 4 inhibitors and pharmaceutical compositions containing the same
IL224544B
(en )
2018-07-31
Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
PL3443957T3
(en )
2021-05-04
Compounds and compositions for the treatment of cancer
IN2012DN03404A
(en )
2015-10-23
EA201270728A1
(en )
2013-01-30
PURINE CONNECTIONS
MX344189B
(en )
2016-12-08
Formulations of mazindol.
MX356727B
(en )
2018-06-12
Modified release formulations of viloxazine.
MY165088A
(en )
2018-02-28
Pharmaceutical compositions comprising alisporivir
IL235154A0
(en )
2014-12-31
Compositions comprising urate-lowering agents and anti-inflammatory agents and uses thereof
ZA201209038B
(en )
2014-02-26
Adhesive slow-release formulations for the local administration of curcumin
ZA201208775B
(en )
2013-08-28
Gel formulations for the topical use of 1-amino-alkycyclohexane derivatives
MX2013008559A
(en )
2013-08-21
Leptin derivatives.
UA59396U
(en )
2011-05-10
Use of compositions of non-steroid anti-inflammatory drugs and caffeine as antiexudative agents
PL2588073T3
(en )
2018-01-31
Cosmetic composition for the nails and use of an isosorbide derivative
IL222642A0
(en )
2012-12-31
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
TN2014000484A1
(en )
2016-03-30
Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
EA201270727A1
(en )
2013-01-30
PURINE CONNECTIONS